Clinical trial
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
NCT00089882 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00089882 |
|---|---|
| Title | Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II |
| Official title | Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | National Human Genome Research Institute (NHGRI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Alzheimer Disease |
| Intervention type | Procedure |
| Interventions | APOE Genetic susceptibility testing |
| Enrollment | 360 |
| Start date | May 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Aug 18, 2004 |
| Last update posted | Jul 23, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: